Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 1
1952 2
1953 6
1954 9
1955 9
1956 10
1957 4
1958 3
1959 13
1960 5
1961 18
1962 17
1963 24
1964 23
1965 28
1966 30
1967 34
1968 36
1969 52
1970 39
1971 51
1972 54
1973 40
1974 62
1975 60
1976 54
1977 81
1978 83
1979 92
1980 83
1981 96
1982 112
1983 102
1984 139
1985 157
1986 169
1987 156
1988 175
1989 189
1990 196
1991 193
1992 206
1993 229
1994 276
1995 280
1996 260
1997 257
1998 300
1999 305
2000 347
2001 381
2002 376
2003 405
2004 397
2005 416
2006 401
2007 409
2008 465
2009 477
2010 550
2011 559
2012 631
2013 623
2014 627
2015 702
2016 725
2017 698
2018 689
2019 668
2020 712
2021 770
2022 797
2023 680
2024 697
2025 711
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,019 results

Results by year

Filters applied: . Clear all
Page 1
Characterizing primary and secondary senescence in vivo.
Sogabe Y, Shibata H, Kabata M, Tanaka A, Mitsunaga K, Sunadome K, Nakajima-Koyama M, Hirano M, Nishida E, Woltjen K, Seno H, Yamada Y, Yamamoto T. Sogabe Y, et al. Among authors: yamamoto t. Nat Aging. 2025 Aug;5(8):1568-1588. doi: 10.1038/s43587-025-00917-y. Epub 2025 Jul 11. Nat Aging. 2025. PMID: 40646305
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y; FEATHER Study Investigators. Kimura K, et al. Among authors: yamamoto t. Am J Kidney Dis. 2018 Dec;72(6):798-810. doi: 10.1053/j.ajkd.2018.06.028. Epub 2018 Sep 1. Am J Kidney Dis. 2018. PMID: 30177485 Free article. Clinical Trial.
2025 ICM: Nutrition.
Wininger AE, Romano CL, Arshi A, Ramasamy B, Atipiboonsin V, Shahi A, Aguilera SP, Barsoum WK, Bingham JS, Budhiparama N, Cheok T, Chinoy MA, Chisari E, Coraça-Huber DC, Cordero JK, Cross MB, Drago L, Dragosloveanu S, Enayatollahi M, Freedhand A, Fujie A, Gahramanov A, Ghazavi MT, Giordano GC, Goswami K, Huddleston J, Jazayeri R, Jennings J, Khalifa A, Kigera J, Longo UG, Meermans G, Megaloikonomos PD, Morii T, Mortazavi SMJ, Moschetti WE, Novikov D, Ong MTY, Otero JE, Ozden VE, Parvizi J, Piuzzi NS, Ramasamy B, Romanó CL, Rosso F, Scheau C, Bogdan L, Spangehl MJ, Stangl WP, Studers P, Tarabichi S, Tuncay I, W-Dahl A, Wik TS, Yamamoto T. Wininger AE, et al. Among authors: yamamoto t. J Arthroplasty. 2025 Oct 30:S0883-5403(25)01380-4. doi: 10.1016/j.arth.2025.10.077. Online ahead of print. J Arthroplasty. 2025. PMID: 41176102 No abstract available.
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan.
Shimose S, Saeki I, Ito T, Takeuchi Y, Tani J, Tomonari T, Sasaki R, Sasaki K, Kakizaki S, Hatanaka T, Iwamoto H, Tanabe N, Yamamoto T, Naganuma A, Shirono T, Kanayama Y, Nishina S, Takayama T, Kobara H, Otsuka M, Kawashima H, Takami T, Kawaguchi T; representing the Hepatology InVestigator Experts in Japan (HIVE-J) Study Group. Shimose S, et al. Among authors: yamamoto t. Hepatol Int. 2025 Aug;19(4):846-855. doi: 10.1007/s12072-025-10781-y. Epub 2025 Feb 28. Hepatol Int. 2025. PMID: 40019708
A multi-kingdom genetic barcoding system for precise clone isolation.
Ishiguro S, Ishida K, Sakata RC, Ichiraku M, Takimoto R, Yogo R, Kijima Y, Mori H, Tanaka M, King S, Tarumoto S, Tsujimura T, Bashth O, Masuyama N, Adel A, Toyoshima H, Seki M, Oh JH, Archambault AS, Nishida K, Kondo A, Kuhara S, Aburatani H, Klein Geltink RI, Yamamoto T, Shakiba N, Takashima Y, Yachie N. Ishiguro S, et al. Among authors: yamamoto t. Nat Biotechnol. 2025 May 21. doi: 10.1038/s41587-025-02649-1. Online ahead of print. Nat Biotechnol. 2025. PMID: 40399693
Monoallelic mutations in MMD2 cause autosomal dominant aggressive periodontitis.
Iwata T, Mizoguchi Y, Yoshimoto T, Tsumura M, Sakura F, Johnson JR, Matsuda S, Ouhara K, Nagatani Y, Asano T, Ohnishi H, Kato Z, Mihara K, Kanegane H, Ueda T, Sasaki S, Taniguchi Y, Ninomiya Y, Ohno Y, Suzuki-Takedachi K, Sotomaru Y, Sakuma T, Yamamoto T, Matsuda Y, Kume K, Sanui T, Nishimura F, Kajiya M, Ueki Y, Kurihara H, Morino H, Okada S, Kawakami H, Mizuno N. Iwata T, et al. Among authors: yamamoto t. J Exp Med. 2025 Sep 1;222(9):e20231911. doi: 10.1084/jem.20231911. Epub 2025 Jul 15. J Exp Med. 2025. PMID: 40663042 Free PMC article.
Global tracking of marine megafauna space use reveals how to achieve conservation targets.
Sequeira AMM, Rodríguez JP, Marley SA, Calich HJ, van der Mheen M, VanCompernolle M, Arrowsmith LM, Peel LR, Queiroz N, Vedor M, da Costa I, Mucientes G, Couto A, Humphries NE, Abalo-Morla S, Abascal FJ, Abercrombie DL, Abrantes K, Abreu-Grobois FA, Afonso AS, Afonso P, Ahonen H, Åkesson S, Alfaro-Shigueto J, Andrews RD, Angelier F, Antonopoulou M, Arata JA, Araujo G, Arauz R, Arcos JM, Arregui I, Arrizabalaga H, Auger-Méthé M, Bach S, Bailleul F, Baird RW, Balazs GH, Barco SG, Barnett A, Baverstock W, Baylis AMM, Beard A, Bécares J, Belda EJ, Bell I, Bennison A, Benson SR, Bernal D, Berumen ML, Bessudo S, Bezerra NPA, Blaison AV, Blanco GS, Block BA, Bolton M, Bond ME, Bonfil R, Braun CD, Broderick AC, Brooke ML, Brooks AML, Brooks EJ, Bruno IM, Burns JM, Byrne ME, Campana SE, Campbell HA, Campbell RA, Carlisle A, Carmichael RH, Carroll G, Casale P, Ceia FR, Chapman DD, Chapple TK, Charrassin JB, Chiaradia A, Chisholm J, Clarke CR, Clay TA, Cleguer C, Clingham E, Clua EEG, Cochran JEM, Constantine R, Cooper RW, Crochelet E, Cronin M, Cuevas E, DaCosta KP, Dagorn L, Daly R, Davis RW, de Bruyn PJN, Delgado-Trejo C, Dellinger T, Derville S, Diamant S, DiMatteo A, Dodge KL, Doherty P… See abstract for full author list ➔ Sequeira AMM, et al. Among authors: yamamoto t. Science. 2025 Jun 5;388(6751):1086-1097. doi: 10.1126/science.adl0239. Epub 2025 Jun 5. Science. 2025. PMID: 40472106
Genome sequencing provides high diagnostic yield and new etiological insights for intellectual disability and developmental delay.
Hamanaka K, Fujita A, Miyatake S, Misawa K, Koshimizu E, Uchiyama Y, Tsuchida N, Seyama R, Sakamoto M, Iwama K, Nishimura N, Utsuno Y, Fu L, Takizawa M, Liang Q, Itai T, Saida K, Ohori S, Kameyama S, Fukuda H, Hayashi Y, Inoue Y, Goto T, Ichikawa K, Kuki I, Fukuoka M, Kim K, Shiohama T, Shimoda K, Otsuka K, Ueda Y, Cho K, Yuge K, Tachi N, Yoshida M, Daida A, Hirasawa K, Yanagishita T, Yamamoto T, Shirai K, Mehr TF, Fattal-Valevski A, Lev D, Yokoyama H, Iwabuchi E, Saito Y, Miura M, Sugai K, Ishiyama A, Sasaki M, Watanabe Y, Takanashi JI, Kim CA, Yokochi K, Tohyama J, Mori T, Izumi Y, Hasegawa Y, Okamoto N, Ikeda T, Osaka H, Kawai Y, Omae Y, Tokunaga K, Kato M, Mizuguchi T, Matsumoto N. Hamanaka K, et al. Among authors: yamamoto t. NPJ Genom Med. 2025 Aug 26;10(1):60. doi: 10.1038/s41525-025-00521-4. NPJ Genom Med. 2025. PMID: 40858643 Free PMC article.
18,019 results
You have reached the last available page of results. Please see the User Guide for more information.